Europe Trypsin Market Size, Share & Trends Analysis Report By Source (Bovine, Porcine and Others), By Application, By End-Use (Industrial use, Research and Diagnostics), By Country and Growth Forecast, 2024 - 2031

Europe Trypsin Market Size, Share & Trends Analysis Report By Source (Bovine, Porcine and Others), By Application, By End-Use (Industrial use, Research and Diagnostics), By Country and Growth Forecast, 2024 - 2031


The Europe Trypsin Market would witness market growth of 4.9% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Trypsin Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $8,232.5 Thousand by 2031. The UK market is exhibiting a CAGR of 4% during (2024 - 2031). Additionally, The France market would experience a CAGR of 5.7% during (2024 - 2031).

In molecular biology and proteomics, trypsin is employed for protein digestion to generate peptide fragments suitable for downstream analysis. Its specificity in cleaving peptide bonds after lysine and arginine residues makes trypsin an ideal enzyme for producing peptides of manageable size for mass spectrometry analysis.

Moreover, digesting complex protein mixtures into smaller peptides, trypsin enables the identification, quantification, and characterization of proteins in biological samples. Proteomic studies using trypsin digestion are invaluable for elucidating protein structures, functions, interactions, and post-translational modifications, thereby advancing our understanding of cellular processes and disease mechanisms.

Belgium’s growing pharmaceutical sector boosts the domestic demand for trypsin, which is essential for various drug development, manufacturing, and research applications. Local pharmaceutical companies’ expanding operations lead to higher consumption of trypsin. According to the International Trade Administration (ITA), Belgium’s industry spends $1.64 billion (€1.5 billion) on R&D annually, equivalent to 40 percent of all private investment made in Belgium.

Based on Source, the market is segmented into Bovine, Porcine and Others. Based on Application, the market is segmented into Biotechnology & Pharmaceutical Industry, Food Industry, Cosmetics & Personal Care, Waste Treatment and Others. Based on End-Use, the market is segmented into Industrial use, Research and Diagnostics. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled
  • Merck Millipore (Merck KGaA)
  • Novozymes A/S (Novo Holdings A/S)
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Promega Corporation
  • Takara Bio Inc. (Takara Holdings Inc.)
  • Sartorius AG
  • PromoCell GmbH
  • Geno Technology, Inc.
  • Bio-Rad Laboratories, Inc.
Europe Trypsin Market Report Segmentation

By Source
  • Bovine
  • Porcine
  • Others
By Application
  • Biotechnology & Pharmaceutical Industry
  • Food Industry
  • Cosmetics & Personal Care
  • Waste Treatment
  • Others
By End-use
  • Industrial use
  • Research
  • Diagnostics
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Trypsin Market, by Source
1.4.2 Europe Trypsin Market, by Application
1.4.3 Europe Trypsin Market, by End-use
1.4.4 Europe Trypsin Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Europe Trypsin Market by Source
4.1 Europe Bovine Market by Country
4.2 Europe Porcine Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Trypsin Market by Application
5.1 Europe Biotechnology & Pharmaceutical Industry Market by Country
5.2 Europe Food Industry Market by Country
5.3 Europe Cosmetics & Personal Care Market by Country
5.4 Europe Waste Treatment Market by Country
5.5 Europe Others Market by Country
Chapter 6. Europe Trypsin Market by End-use
6.1 Europe Industrial use Market by Country
6.2 Europe Research Market by Country
6.3 Europe Diagnostics Market by Country
Chapter 7. Europe Trypsin Market by Country
7.1 Germany Trypsin Market
7.1.1 Germany Trypsin Market by Source
7.1.2 Germany Trypsin Market by Application
7.1.3 Germany Trypsin Market by End-use
7.2 UK Trypsin Market
7.2.1 UK Trypsin Market by Source
7.2.2 UK Trypsin Market by Application
7.2.3 UK Trypsin Market by End-use
7.3 France Trypsin Market
7.3.1 France Trypsin Market by Source
7.3.2 France Trypsin Market by Application
7.3.3 France Trypsin Market by End-use
7.4 Russia Trypsin Market
7.4.1 Russia Trypsin Market by Source
7.4.2 Russia Trypsin Market by Application
7.4.3 Russia Trypsin Market by End-use
7.5 Spain Trypsin Market
7.5.1 Spain Trypsin Market by Source
7.5.2 Spain Trypsin Market by Application
7.5.3 Spain Trypsin Market by End-use
7.6 Italy Trypsin Market
7.6.1 Italy Trypsin Market by Source
7.6.2 Italy Trypsin Market by Application
7.6.3 Italy Trypsin Market by End-use
7.7 Rest of Europe Trypsin Market
7.7.1 Rest of Europe Trypsin Market by Source
7.7.2 Rest of Europe Trypsin Market by Application
7.7.3 Rest of Europe Trypsin Market by End-use
Chapter 8. Company Profiles
8.1 Merck Millipore (Merck KGaA)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Lonza Group Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 SWOT Analysis
8.3 Agilent Technologies, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Thermo Fisher Scientific, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 Promega Corporation
8.5.1 Company Overview
8.5.2 SWOT Analysis
8.6 Takara Bio Inc. (Takara Holdings Inc.)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.7 Sartorius AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 PromoCell GmbH
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 Geno Technology, Inc.
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Bio-Rad laboratories, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings